CC-223

Overview

CC-223, a mTOR kinase inhibitor, has been found to be effective in inducing the apoptosis and reducing the proliferation of tumor cells. It is still under Phase I/II clinical trial by Celgene Corporation. IC50: 16 nM.

Application

Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Cancer | mTOR

Product Information

• Catalog No.: B0084-474093
• CAS No.: 1228013-30-6
• Molecular Formula: C21H27N5O3
• Molecular Weight: 397.47
• Purity: 98%
• Storage: -20°C Freeze
• Solubility: DMSO: ≥ 27 mg/mL

Source

Original product source